Prothena (NASDAQ:PRTA) had its price target raised by analysts at Citizens Jmp from $11.00 to $19.00. They now have a "market outperform" rating on the stock.
Prothena (NASDAQ:PRTA) was given a new $19.00 price target on by analysts at Deutsche Bank Aktiengesellschaft.
Prothena (NASDAQ:PRTA) was given a new $19.00 price target on by analysts at JMP Securities.
Prothena (NASDAQ:PRTA) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Why The Narrative Around Prothena Is Shifting After Analysts Raise Targets and Clinical Updates [Yahoo! Finance]